Moreover, another study showed that activation of Toll-like receptor-9 (TLR-9) by CpG (TLR-9 ligand) enhanced the maturation and differentiation of MDSCs, and effectively decreased the percentage of Ly6Ghi MDSCs in melanoma and CRC tumor models [101]. The gene discussed is TLR9; the disease is melanoma.